FDA Adverse Event Injury Summary report: N

ENDEAVOR RX CORONARY STENT SYSTEM

MDR report key: 1083005 · Received July 28, 2008

Report

Report Number
2953200-2008-00608
Event Type
Injury
Date Received
July 28, 2008
Date of Event
November 26, 2007
Report Date
June 27, 2008
Manufacturer
MEDTRONIC CARDIOVASCULAR GALWAY
Product Code
NIQ
PMA / PMN Number
P060033
Removal / Correction Number
NA
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
AS
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

SECONDARY INTERVENTION - EVALUATION RESULTS: INHERENT RISK OF PROCEDURE (HEMORRHAGE REQUIRING TRANSFUSION).

Description of Event or Problem · 1

ONE ENDEAVOR STENT (2.75 X 14MM) WAS IMPLANTED TO THE PROXIMAL LAD. THE PATIENT SUFFERED SPONTANEOUS GASTROINTESTINAL BLEEDING ON THREE DAYS POST STENT IMPLANT. THE INVESTIGATOR REPORTED THAT THE EVENT WAS NOT RELATED TO THE STUDY STENT. PRBC TRANSFUSION CARRIED OUT. PATIENT WAS REPORTED TO BE ASYMPTOMATIC AT THE 30 DAY & 6 MONTH FOLLOW UP. PLEASE NOTE THAT THIS DEVICE IS NOT DISTRIBUTED IN THE UNITED STATES.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 ENDEAVOR RX CORONARY STENT SYSTEM NIQ MEDTRONIC CARDIOVASCULAR GALWAY NA UNK

Patients

Seq Age Sex Outcome Treatment
1 UNK Required Intervention CLOPIDOGREL - 24 HRS PRIOR TO THE EVENT| ASA - 24 HRS PRIOR TO THE EVENT| TICLOPIDINE - 24 HOURS PRIOR TO THE EVENT